379 related articles for article (PubMed ID: 18594928)
1. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
Neto JD; de Oliveira SF; Vianna SP; Terra RM
Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy.
Agarwal R; Aggarwal AN; Gupta D
Respirology; 2006 Jan; 11(1):105-8. PubMed ID: 16423210
[TBL] [Abstract][Full Text] [Related]
4. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
5. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
Kelly-Garcia J; Roman-Berumen JF; Ibarra-Perez C
Arch Med Res; 1997; 28(4):583-5. PubMed ID: 9428588
[TBL] [Abstract][Full Text] [Related]
6. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
7. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
8. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata.
Dey A; Bhuniya S; Datta Chaudhuri A; Pandit S; Saha-Dutta Chowdhury M; Sengupta A; Saha I; De P
Singapore Med J; 2010 Feb; 51(2):163-5. PubMed ID: 20358157
[TBL] [Abstract][Full Text] [Related]
9. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
Luh SP; Chen CY; Tzao CY
Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
[TBL] [Abstract][Full Text] [Related]
11. Safety Profile of the Use of Iodopovidone for Pleurodesis in Patients with Malignant Pleural Effusion.
Andrade Neto JD; Terra RM; Teixeira RM; Pereira SV; Pego-Fernandes PM
Respiration; 2015; 90(5):369-75. PubMed ID: 26439936
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of iodopovidone pleurodesis through chest tube in spontaneous pneumothorax.
Mahmodlou R; Rahimi-Rad MH; Alizadeh H
Pneumologia; 2011; 60(2):78-80. PubMed ID: 21823357
[TBL] [Abstract][Full Text] [Related]
13. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis.
Agarwal R; Paul AS; Aggarwal AN; Gupta D; Jindal SK
Respirology; 2011 Oct; 16(7):1064-9. PubMed ID: 21605278
[TBL] [Abstract][Full Text] [Related]
15. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions.
Sahin U; Unlü M; Akkaya A; Ornek Z
Respiration; 2001; 68(5):501-5. PubMed ID: 11694813
[TBL] [Abstract][Full Text] [Related]
16. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
17. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
18. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
20. Iodopovidone pleurodesis does not effect thyroid function in normal adults.
Yeginsu A; Karamustafaoglu A; Ozugurlu F; Etikan I
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):563-4. PubMed ID: 17669938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
